{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:59Z","timestamp":1790805359925,"version":"4.1.0"},"reference-count":50,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Jaime Erin Follicular Lymphoma Consortium, Department of Defense"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA97274"],"award-info":[{"award-number":["P50 CA97274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,6,2]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>CD8<jats:sup>+<\/jats:sup> T-lymphocyte subsets defined by killer lectin-like receptor G1 (KLRG1) and CD127 expression have been reported to have an important role in infection, but their role in the setting of lymphoid malignancies, specifically follicular lymphoma (FL), has not been studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To characterize the phenotype of KLRG1\/CD127-defined CD8<jats:sup>+<\/jats:sup> subsets, surface and intracellular markers were measured by flow cytometry and Cytometry by time of flight (CyTOF), and the transcriptional profile of these cells was determined by CITE-Seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing). The functional capacity of each subset was determined, as was their impact on overall survival (OS) and event-free survival (EFS) of patients with FL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found that intratumoral CD8<jats:sup>+<\/jats:sup> cells in FL are skewed toward effector cell subsets, particularly KLRG<jats:sup>+<\/jats:sup>CD127<jats:sup>-<\/jats:sup> and KLRG1<jats:sup>-<\/jats:sup>CD127<jats:sup>-<\/jats:sup> cells over memory cell subsets, such as KLRG1<jats:sup>-<\/jats:sup>CD127<jats:sup>+<\/jats:sup> and KLRG1<jats:sup>+<\/jats:sup>CD127<jats:sup>+<\/jats:sup> cells. While effector subsets exhibited increased capacity to produce cytokines\/granules when compared with memory subsets, their proliferative capacity and viability were found to be substantially inferior. Clinically, a skewed distribution of intratumoral CD8<jats:sup>+<\/jats:sup> T cells favoring effector subtypes was associated with an inferior outcome in patients with FL. Increased numbers of CD127<jats:sup>+<\/jats:sup>KLRG1<jats:sup>-<\/jats:sup> and CD127<jats:sup>+<\/jats:sup>KLRG1<jats:sup>+<\/jats:sup> were significantly associated with a favorable OS and EFS, while CD127<jats:sup>-<\/jats:sup>KLRG1<jats:sup>-<\/jats:sup> correlated with a poor EFS and OS in patients with FL. Furthermore, we demonstrated that interleukin (IL)-15 promotes CD127<jats:sup>-<\/jats:sup>KLRG1<jats:sup>+<\/jats:sup> cell development in the presence of dendritic cells via a phosphoinositide 3-kinase (PI3K)-dependent mechanism, and treatment of CD8<jats:sup>+<\/jats:sup> T cells with a PI3K inhibitor downregulated the transcription factors responsible for CD127<jats:sup>-<\/jats:sup>KLRG1<jats:sup>+<\/jats:sup> differentiation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Taken together, these results reveal not only a biological and prognostic role for KLRG1\/CD127-defined CD8<jats:sup>+<\/jats:sup> subsets in FL but also a potential role for PI3K inhibitors to manipulate the differentiation of CD8<jats:sup>+<\/jats:sup> T cells, thereby promoting a more effective antitumor immune response.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2021-002662","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T12:01:08Z","timestamp":1625486468000},"page":"e002662","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Expression of KLRG1 and CD127 defines distinct CD8<sup>+<\/sup> subsets that differentially impact patient outcome in follicular lymphoma"],"prefix":"10.1136","volume":"9","author":[{"given":"Hongyan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Immunology, Medical College, China Three Gorges University, Yichang, Hubei, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Jalali","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C","family":"Pritchett","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Villasboas","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J","family":"Novak","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-2300","authenticated-orcid":false,"given":"Zhi-Zhang","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"2025100306454835000_9.7.e002662.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.56.1","article-title":"Follicular lymphoma: the role of the tumor microenvironment in prognosis","volume":"56","author":"Sugimoto","year":"2016","journal-title":"J Clin Exp Hematop"},{"key":"2025100306454835000_9.7.e002662.2","first-page":"810","article-title":"The tumor microenvironment in follicular lymphoma","volume":"10","author":"Yang","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"2025100306454835000_9.7.e002662.3","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.1"},{"key":"2025100306454835000_9.7.e002662.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0513"},{"key":"2025100306454835000_9.7.e002662.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3376"},{"key":"2025100306454835000_9.7.e002662.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2487"},{"key":"2025100306454835000_9.7.e002662.7","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","article-title":"Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma","volume":"26","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"key":"2025100306454835000_9.7.e002662.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.1648"},{"key":"2025100306454835000_9.7.e002662.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082578"},{"key":"2025100306454835000_9.7.e002662.10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0266"},{"key":"2025100306454835000_9.7.e002662.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018218"},{"key":"2025100306454835000_9.7.e002662.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"2025100306454835000_9.7.e002662.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.3.1309"},{"key":"2025100306454835000_9.7.e002662.14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01595","article-title":"Striking a Balance-Cellular and molecular drivers of memory T cell development and responses to chronic stimulation","volume":"10","author":"Hope","year":"2019","journal-title":"Front Immunol"},{"key":"2025100306454835000_9.7.e002662.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol"},{"key":"2025100306454835000_9.7.e002662.16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ai.2017.12.003","article-title":"The fate choice between effector and memory T cell lineages: asymmetry, signal integration, and feedback to create bistability","volume":"137","author":"Backer","year":"2018","journal-title":"Adv Immunol"},{"key":"2025100306454835000_9.7.e002662.17","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.146"},{"key":"2025100306454835000_9.7.e002662.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162674","article-title":"Dicer regulates the balance of short-lived effector and long-lived memory CD8 T cell lineages","volume":"11","author":"Baumann","year":"2016","journal-title":"PLoS One"},{"key":"2025100306454835000_9.7.e002662.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.008"},{"key":"2025100306454835000_9.7.e002662.20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0558"},{"key":"2025100306454835000_9.7.e002662.21","article-title":"Web-Based analysis and publication of flow cytometry experiments","volume":"Chapter 10","author":"Kotecha","year":"2010","journal-title":"Curr Protoc Cytom"},{"key":"2025100306454835000_9.7.e002662.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2025100306454835000_9.7.e002662.23","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2025100306454835000_9.7.e002662.24","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12471"},{"key":"2025100306454835000_9.7.e002662.25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.4834"},{"key":"2025100306454835000_9.7.e002662.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.01.004"},{"key":"2025100306454835000_9.7.e002662.27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000206395","article-title":"Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features","volume":"72","author":"Fasola","year":"1984","journal-title":"Acta Haematol"},{"key":"2025100306454835000_9.7.e002662.28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1822"},{"key":"2025100306454835000_9.7.e002662.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059456"},{"key":"2025100306454835000_9.7.e002662.30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59806"},{"key":"2025100306454835000_9.7.e002662.31","doi-asserted-by":"crossref","first-page":"61425","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"2025100306454835000_9.7.e002662.32","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.84"},{"key":"2025100306454835000_9.7.e002662.33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/eji.201847897","article-title":"Expression of IL-7R\u03b1 and KLRG1 defines functionally distinct CD8+ T-cell populations in humans","volume":"49","author":"Remmerswaal","year":"2019","journal-title":"Eur J Immunol"},{"key":"2025100306454835000_9.7.e002662.34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","article-title":"KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity","volume":"48","author":"Herndler-Brandstetter","year":"2018","journal-title":"Immunity"},{"key":"2025100306454835000_9.7.e002662.35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6451-9_7"},{"key":"2025100306454835000_9.7.e002662.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.07.010"},{"key":"2025100306454835000_9.7.e002662.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-160945"},{"key":"2025100306454835000_9.7.e002662.38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546000"},{"key":"2025100306454835000_9.7.e002662.39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-156307"},{"key":"2025100306454835000_9.7.e002662.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81261"},{"key":"2025100306454835000_9.7.e002662.41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.10.5018"},{"key":"2025100306454835000_9.7.e002662.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003457107"},{"key":"2025100306454835000_9.7.e002662.43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00020"},{"key":"2025100306454835000_9.7.e002662.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol Cancer"},{"key":"2025100306454835000_9.7.e002662.45","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000113"},{"key":"2025100306454835000_9.7.e002662.46","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxr078"},{"key":"2025100306454835000_9.7.e002662.47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.it.2017.02.003","article-title":"Transcription factor T-bet orchestrates lineage development and function in the immune system","volume":"38","author":"Kallies","year":"2017","journal-title":"Trends Immunol"},{"key":"2025100306454835000_9.7.e002662.48","doi-asserted-by":"publisher","DOI":"10.1038\/ni1268"},{"key":"2025100306454835000_9.7.e002662.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.095"},{"key":"2025100306454835000_9.7.e002662.50","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.celrep.2018.01.072","article-title":"Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation","volume":"22","author":"Danilo","year":"2018","journal-title":"Cell Rep"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2021-002662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:45:53Z","timestamp":1759499153000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2021-002662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,5]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/jitc-2021-002662"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2021-002662","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}